A 22-Year Chronicle: The Rise of China’s Innovative Drugs

Apr 23,2026

In an industry, capital, talent, information and opportunities often first emerge where people gather.

CPIC 2026 | The Go-Global Formula: New Models, New Challenges, and New Strategies for Cross-Border Pharmaceutical Partnerships

Apr 22,2026

JunHe Law Firm and TONACEA are jointly hosting this special session, bringing together a number of JunHe experts in hot-topic legal areas within the pharmaceutical industry to share insights and engage in in-depth discussions on key issues.

Decree No. 818: Who Will Be Left Out?

Apr 22,2026

The NHC's Narrow Gate

CPIC 2026 | TONACEA and NAPPA Officially Sign Strategic Cooperation Agreement

Apr 22,2026

TONACEA, a renowned industrial ecosystem platform in China's biomedical innovation sector, has officially reached a strategic cooperation agreement with the North American Pharmaceutical Professionals Alliance (NAPPA).

CPIC 2026 | Call for Applications! Young Elite Fellowship Program Officially Launched

Apr 22,2026

This is the most anticipated premier event in China's biopharmaceutical field in 2026, and also a historic moment for young professionals in China's pharmaceutical industry.

CPIC 2026 | Chinese Biotech: Integrated R&D, Manufacturing & Commercialization vs. Specialized Division of Labor

Apr 22,2026

This year's conference features a series of special roundtable sessions focused on in-depth discussions of core industry issues. Among them, the debate on "Chinese Biotech: Integrated R&D, Manufacturing & Commercialization vs. Specialized Division of Labor" has been passionately curated by Tao Qiucheng of Yatai Capital!

CPIC 2026 | China-Japan Health Industry Collaboration Forum

Apr 21,2026

China-Japan Pharmaceutical Cooperation Is Entering a New Phase

CPIC 2026 | Four Organizations Become Guiding Institutions of the Conference

Apr 21,2026

Authoritative Endorsement! The Conference Receives Comprehensive Guidance and Support from Shanghai's Core Biomedical Institutions.
< 1...202122...26 > proceed page